[ORGANIZATION]
Jazz Pharmaceuticals
Featured in 4 tracked stories · first seen
Situations
Jazz Pharmaceuticals Ziihera oncology developments
2 clusters · 2 sources · last updated
Latest: Jazz Pharmaceuticals launches Ziihera following FDA approval for GEA
In August 2026, Jazz Pharmaceuticals and Purple Biotech reported significant developments in oncology. Jazz Pharmaceuticals published Phase 3 trial results for Ziihera (zanidatamab-hrii) in the New England Journal of Med
CNH Industrial financial outlook and India expansion
2 clusters · 3 sources · last updated
Latest: CNH Industrial raises EPS estimates and announces India investment plan
CNH Industrial has reported positive financial developments and expansion plans. Following a second-quarter revenue of $4.80 billion, the company raised its full-year earnings per share (EPS) outlook to a range of $0.41
Also covered in
-
Jazz Pharmaceuticals to acquire Actio Biosciences for up to $1.32 billion
[BUSINESS] · 7 sources ·